Yuanxin Tech, a Beijing-based health-tech company, has filed for its sixth attempt at an IPO on the Hong Kong Stock Exchange. The company is seeking a valuation of 19.5 billion yuan (approximately $2.7 billion). Its business model connects online medical consultations with offline pharmacy services, and it has received backing from prominent investors such as Sequoia China and Tencent. AI
排序理由 Company files for IPO with significant valuation and backing from major investors. [lever_c_demoted from significant: ic=1 ai=0.1]
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
